Drug intelligence / Profile preview

Flumethovix

Development stage
Unknown
Lead developer
Primary Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Flumethovix is a combination topical medication containing fluocinonide, a synthetic glucocorticoid corticosteroid, and dimethicone, a silicone-based skin protectant[1]. Fluocinonide is a potent anti-inflammatory and immunosuppressive agent used to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis[1]. Its mechanism of action involves binding to cytosolic glucocorticoid receptors, which leads to modulation of gene expression and suppression of pro-inflammatory mediators, ultimately reducing swelling, redness, and itching[1]. Dimethicone provides a protective barrier and helps retain skin moisture, alleviating dryness and irritation[1]. This combination is indicated for the management of inflammatory skin conditions, offering both anti-inflammatory effects and skin protection.

Brand names
Flumethovix
Other names
Fluocinonide + Dimethicone Kit
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Flumethovix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flumethovix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call